These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7810701

  • 21. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.
    Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S.
    Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Altered functional characteristics of rat macrophages during nephrosis. Synergistic effects of hypercholesterolemia.
    Diamond JR, Pesek I, McCarter MD, Karnovsky MJ.
    Am J Pathol; 1989 Oct; 135(4):711-8. PubMed ID: 2801885
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury.
    Hattori M, Nikolic-Paterson DJ, Miyazaki K, Isbel NM, Lan HY, Atkins RC, Kawaguchi H, Ito K.
    Kidney Int Suppl; 1999 Jul; 71():S47-50. PubMed ID: 10412736
    [Abstract] [Full Text] [Related]

  • 25. Addition of oleic acid to delipidated bovine serum albumin aggravates renal damage in experimental protein-overload nephrosis.
    van Timmeren MM, Bakker SJ, Stegeman CA, Gans RO, van Goor H.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2349-57. PubMed ID: 16144858
    [Abstract] [Full Text] [Related]

  • 26. Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis.
    Hosoyamada M, Yan K, Nishibori Y, Takiue Y, Kudo A, Kawakami H, Shibasaki T, Endou H.
    J Pharmacol Sci; 2005 Feb; 97(2):234-41. PubMed ID: 15684566
    [Abstract] [Full Text] [Related]

  • 27. Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades.
    Eddy AA.
    Kidney Int; 1998 May; 53(5):1182-9. PubMed ID: 9573532
    [Abstract] [Full Text] [Related]

  • 28. Hypercholesterolemia is a prerequisite for puromycin inducible damage in mouse kidney.
    Cheng ZZ, Pätäri A, Aalto-Setälä K, Novikov D, Schlöndorff D, Holthöfer H.
    Kidney Int; 2003 Jan; 63(1):107-12. PubMed ID: 12472773
    [Abstract] [Full Text] [Related]

  • 29. Increased glomerular capillary pressure alters glomerular cytokine expression.
    Shankland SJ, Ly H, Thai K, Scholey JW.
    Circ Res; 1994 Nov; 75(5):844-53. PubMed ID: 7923630
    [Abstract] [Full Text] [Related]

  • 30. Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis.
    Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H.
    Lab Invest; 1991 May; 64(5):640-7. PubMed ID: 2030578
    [Abstract] [Full Text] [Related]

  • 31. Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-beta 1.
    Kitamura M.
    J Immunol; 1997 Aug 01; 159(3):1404-11. PubMed ID: 9233637
    [Abstract] [Full Text] [Related]

  • 32. Involvement of MCP-1 and M-CSF in glomerular foam cell formation in ExHC rats.
    Kodama N, Otani H, Yamada Y, Mune M, Yukawa S.
    Kidney Int Suppl; 1999 Jul 01; 71():S174-7. PubMed ID: 10412769
    [Abstract] [Full Text] [Related]

  • 33. Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis.
    Okuda S, Nakamura T, Yamamoto T, Ruoslahti E, Border WA.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9765-9. PubMed ID: 1946401
    [Abstract] [Full Text] [Related]

  • 34. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .
    Kitamura M, Sütö T, Yokoo T, Shimizu F, Fine LG.
    J Immunol; 1996 Apr 15; 156(8):2964-71. PubMed ID: 8609417
    [Abstract] [Full Text] [Related]

  • 35. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH, Boggs KP, Burke FC.
    Int J Pediatr Nephrol; 1985 Apr 15; 6(2):117-20. PubMed ID: 4030221
    [Abstract] [Full Text] [Related]

  • 36. Glomerular expression and cell origin of transforming growth factor-beta 1 in anti-glomerular basement membrane disease.
    Lianos EA, Orphanos V, Cattell V, Cook T, Anagnou N.
    Am J Med Sci; 1994 Jan 15; 307(1):1-5. PubMed ID: 8291500
    [Abstract] [Full Text] [Related]

  • 37. Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis.
    Nakamura T, Ebihara I, Fukui M, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H.
    J Am Soc Nephrol; 1995 Feb 15; 5(8):1585-90. PubMed ID: 7756592
    [Abstract] [Full Text] [Related]

  • 38. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
    Hartner A, Hilgers KF, Bitzer M, Veelken R, Schöcklmann HO.
    J Mol Med (Berl); 2003 Jan 15; 81(1):32-42. PubMed ID: 12545247
    [Abstract] [Full Text] [Related]

  • 39. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
    Holthöfer H, Reivinen J, Solin ML, Haltia A, Miettinen A.
    Am J Pathol; 1996 Sep 15; 149(3):1009-15. PubMed ID: 8780404
    [Abstract] [Full Text] [Related]

  • 40. A study of VEGF and its receptors in two rat models of proteinuria.
    Kanellis J, Levidiotis V, Khong T, Cox AJ, Stacker SA, Gilbert RE, Cooper ME, Power DA.
    Nephron Physiol; 2004 Sep 15; 96(1):P26-36. PubMed ID: 14752241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.